Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies

Journal of Virology

Volumn 70, Issue 1, 1996, Pages 617-622

  Matteucci, Donatella ^a   Pistello, Mauro ^a   Mazzetti, Paola ^a   Giannecchini, Simone ^a   Del Mauro, Daniela ^a   Zaccaro, Lucia ^a   Bandecchi, Patrizia ^a   Tozzini, Franco ^a   Bendinelli, Mauro ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; NEUTRALIZING ANTIBODY; VACCINE;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CAT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FELINE IMMUNODEFICIENCY VIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; T LYMPHOCYTE; VACCINATION; VIRUS CULTURE;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODIES, VIRAL; BASE SEQUENCE; CATS; CELL LINE; DNA PRIMERS; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; IMMUNODEFICIENCY VIRUS, FELINE; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; REPETITIVE SEQUENCES, NUCLEIC ACID; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; VIRAL VACCINES;

EID: 0029655516     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.1.617-622.1996     Document Type: Article

References (53)

1. Ahmad, S., B. Lohman, M. Marthas, L. Giavedoni, Z. El-Amad, N. L. Haigwood, C. J. Scandella, M. B. Gardner, P. A. Luciw, and T. Yilma. 1994. Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. AIDS Res Hum. Retroviruses 10:195-204.
2. Arthur, L. O., J. W. Bess, Jr., R. C. Sowder H, R. E. Benveniste, D. L. Mann, J.-C. Chermann, and L. E. Henderson. 1992 Cellular proteins bound to immunodeficiency viruses, implications for pathogenesis and vaccines. Science 258:1935-1938
3. Avrameas, A., J.-G. Guillet, L. Chouchane, A. Moraillon, P. Sonigo, and A. D. Strosberg, 1992. Localization of three epitopes of the env protein of feline immunodeficiency virus.. Mol Immunol 29:565-572.
4. Baldinotti, F., D. Matteucci, P. Mazzetti, C. Giannelli, P. Bandecchi, F. Tozzini, and M. Bendinelli. 1994 Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system. J Virol. 68:4572-4579.
5. Beebe, A. M., N. Dua, T. G. Faith, P. F. Moore, N. C. Pedersen, and S. Dandekar. 1994. Primary stage of feline immunodeficiency virus infection viral dissemination and cellular targets. J. Virol. 68:3080-3091
6. Bendinelli, M., M. Pistello, S. Lombardi, A. Poli, C. Garzelli, D. Matteucci, L. Ceccherini-Nelli, G. Malvaldi, and F. Tozzini. 1995 Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen Clin Microbiol. Rev. 8:87-120.
7. Bergmeier, L. A., J. Walker, L. Tao, M. Cranage, and T. Lehner. 1994. Antibodies to human and non-human primate cellular and culture medium components in macaques vaccinated with the simian immunodeficiency virus. Immunology 83:213-220.
8. Cammarota, G. Unpublished data
9. Cease, K. B., and J. A. Berzofsky. 1994. Toward a vaccine for AIDS: the emergence of immunobiology-based vaccine development Annu Rev. Immunol. 12:923-989
10. Cohen, J. 1993. Jitters jeopardize AIDS vaccine trials. Science 262:980-981.
11. Cranage, M. P., N. Polyanskaya, B. McBride, N. Cook, L. A. E. Ashworth, M. Dennis, A. Baskerville, P. J. Greenaway, T. Corcoran, P. Kitchin, J. Rose, M. Murphey-Corb, R. C. Desrosiers, E. J. Stott, and G. H. Farrar. 1993. Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus AIDS Res. Hum Retroviruses 9:13-22.
12. Desrosiers, R. C. 1994 Safety issues facing development of a live-attenuated, multiply deleted HIV-1 vaccine AIDS Res. Hum. Retroviruses 10:331-332.
13. English, R. V., P. Nelson, C. M. Johnson, M. Nassise, W. A. Tompkins, and M. B. Tompkins. 1994 Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J Infect. Dis. 170:543-552.
14. Flynn, J. N., C. A. Cannon, J. A. Beatty, M. Mackett, M. A. Rigby, J. C. Neil, and O. Jarrett. 1994. Induction of feline immunodeficiency virus specific cytotoxic T cells in vivo with carrier-free synthetic peptide. J Virol. 68:5835-5844
15. Fontenot, J. D., E. A. Hoover, J. H. Elder, and R. C. Montelaro. 1992. Evaluation of feline immunodeficiency virus and feline leukemia virus trans-membrane peptides for serological diagnosis J. Clin. Microbiol. 30:1885-1890.
16. Gardner, M. B. 1991. Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents. Antivir. Res. 15:267-286.
17. Golding, H., M. P. D'sousa, J. Bradac, B. Mathieson, and P. Fast. 1994. Meeting report. Neutralization of HIV-1. AIDS Res. Hum Retroviruses 10:633-643.
18. Haynes, B. F. 1993. Scientific and social issues of human immunodeficiency virus vaccine development. Science 260:1279-1286.
19. Hosie, M. J. 1994. The development of a vaccine against feline immunodeficiency virus. Br. Vet. J 150:25-39.
20. Hosie, M. J., R. Osborne, G. Reid, J. C. Neil, and O. Jarrett. 1992. Enhancement after feline immunodeficiency virus vaccination. Vet. Immunol. Immunopathol. 35:191-197.
21. Hosie, M. J., R. Osborne, J. K. Yamamoto, J. C. Neil, and O. Jarrett. 1995. Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J. Virol. 69:1253-1255.
22. Israel, Z. R., P. F. Edmonson, D. H. Maul, S. P. O'Neil, S. P. Mossman, C. Thiriart, L. Fabry, O. van Opstal, C. Bruck, F. Bex, A. Burny, P. N. Fultz, J. I. Mullins, and E. A. Hoover. 1994 Incomplete protection, but suppression of viral burden, elicited by subunit simian immunodeficiency virus vaccines. J Virol. 68:1843-1853.
23. Kabat, D., S. L. Kozak, K. Wehrly, and B. Chesebro. 1994. Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1. J. Virol. 68:2570-2577.
24. Kusumi, K., B. Conway, S. Cunningham, A. Berson, C. Evans, A. K. N. Iversen, D. Colvin, M. V. Gallo, S. Coutre, E. G. Shpaer, D. V. Faulkner, A. deRonde, S. Volkman, C. Williams, M. S. Hirsch, and J. I. Mullins. 1992 Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro J. Virol. 66:875-885
25. Langlois, A. J., K. J. Weinhold, T. J. Matthews, M. L. Greenberg, and D. P. Bolognesi. 1992. The ability of certain SIV vaccines to provoke reactions against normal cells. Science 255:292-293
26. Layne, S. P., M. J. Merges, M. Dembo, J. L. Spouge, S. R. Conley, J. P. Moore, J. L. Raina, H. Renz, H. R. Gelderblom, and P. L. Nara. 1992. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus Virology 189:695-714.
27. Lombardi, S., C. Garzelli, C. La Rosa, L. Zaccaro, S. Specter, G. Malvaldi, F. Tozzini, F. Esposito, and M. Bendinelli. 1993. Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope J Virol. 67:4742-4749.
28. Lombardi, S., C. Garzelli, M. Pistello, C. Massi, D. Matteucci, F. Baldinotti, G. Cammarota, L. Da Prato, P. Bandecchi, F. Tozzini, and M. Bendinelli. 1994. A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity J. Virol. 68:8374-8379.
29. Lombardi, S., A. Poli, C. Massi, F. Abramo, L. Zaccaro, A. Bazzichi, G. Malvaldi, M. Bendinelli, and C. Garzelli. 1994. Detection of feline immunodeficiency virus p24 antigen and p24-specific antibodies by monoclonal antibody-based assays. J Virol. Methods 46:287-301.
30. Lutz, H., R. Hofmann-Lehman, K. Bauer-Pham, E. Hoiznagel, F. Tozzini, M. Bendinelli, G. Reubel, A. Aubert, D. Davis, B. Cox, and E. Young. 1995. FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection. Vet. Immunol Immunopathol. 46:103-113.
31. Mascola, J. R., J. Louwagie, F. E. McCutchan, C. L. Fischer, P. A. Hegerich, K. F. Wagner, A. K. Fowler, J. G. McNeil, and D. S. Burke. 1994 Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype. J. Infect. Dis. 169:48-54.
32. Matteucci, D., F. Baldinotti, P. Mazzetti, M. Pistello, P. Bandecchi, R. Ghilarducci, A. Poli, F. Tozzini, and M. Bendinelli. 1993 Detection of feline immunodeficiency virus in saliva and plasma by cultivation and polymerase chain reaction. J. Clin. Microbiol. 31:494-501.
33. Matteucci, D., P. Mazzetti, F. Baldinotti, L. Zaccaro, and M. Bendinelli. 1995. The feline lymphoid cell line MBM and its use for feline immunodeficiency virus isolation and quantitation. Vet. Immunol. Immunopathol. 46:71-82
34. Montefiori, D. C. 1993. In vitro correlates of HIV and SIV humoral immunity and infection enhancement. AIDS Res. Rev. 3:161-183.
35. Moore, J. P., Y. Cao, L. Qing, Q. J. Sattentau, J. Pyati, R. Koduri, J. Robinson, C. F. Barbas III, D. R. Burton, and D. D. Ho. 1995. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120. and their neutralization is not predicted by studies with monomeric gp120 J. Virol. 69:101-109
36. Murphey-Corb, M., L. N. Martin, B. Davison-Fairburn, R. C. Montelaro, M. Miller, M. West, S. Ohkawa, G. B. Baskin, J. Y. Zhang, S. D. Putney, A. C. Allison, and D. A. Eppstein. 1989. A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 246:1293-1297.
37. Orentas, R. J., and J. E. K. Hildreth. 1993. Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res. Hum. Retroviruses 9:1157-1165.
38. Pedersen, N. C. 1993. Feline immunodeficiency virus infection, p. 181-228. In J. A. Levy (ed.), The retroviruses, vol. 2. Plenum Press. New York
39. Pedersen, N. C., E. W. Ho, M. L. Brown, and J. K. Yamamoto. 1987. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome Science 235:790-793.
40. Pistello, M., S. Menzo, M. Giorgi, L. Da Prato, G. Cammarota, M. Clementi, and M. Bendinelli. 1994. Competitive polymerase chain reaction for quantitating feline immunodeficiency virus load in infected cat tissues. Mol Cell. Probes 8:229-234.
41. Rigby, M. A., E. C. Holmes, M. Pistello, A. Mackay, A. J. Leigh Brown, and J. C. Neil. 1993. Evolution of structural proteins of feline immunodeficiency virus: molecular characterization and evidence of selection for change J. Gen. Virol. 74:425-436.
42. Saifuddin, M., M. Ghassemi, C. Patki, C. J. Parker, and G. T. Spear. 1994 Host cell components affect the sensitivity of HIV type 1 to complement-mediated virolysis. AIDS Res. Hum. Retroviruses 10:829-837.
43. Sawyer, L. S. W., M. T. Wrin, L. Crawford-Micsza, B. Potts, Y. Wu, P. A. Weber, R. D. Alfonso, and C. V. Hanson. 1994 Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated. J. Virol. 68:1342-1349.
44. Siebelink, K. H. J., E. Tijhaar, R. C. Huisman, W. Huisman, A. deRonde, I. H. Darby, M. J. Francis, G. F. Rimmelzwaan, and A. D. M. E. Osterhaus. 1995. Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. J. Virol. 69:3704-3711.
45. Sodora, D. L., E. G. Shpaer, B. E. Kitchell, S. W. Dow, E. A. Hoover, and J. I. Mullins. 1994. Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J. Virol 68:2230-2238.
46. Stott, E. J. 1994 Toward a vaccine against AIDS. lessons from simian immunodeficiency virus vaccines. Curr. Top Microbiol. Immunol. 188:221-237.
47. Tozzini, F., D. Matteucci, P. Bandecchi, F. Baldinotti, K. H. J. Siebelink, A. Osterhaus, and M. Bendinelli. 1993 Neutralizing antibodies in cats infected with feline immunodeficiency virus. J. Clin. Microbiol. 31:1626-1629
48. Verschoor, E. J., A. L. W. van Vliet, H. F. Egberink, W. Hesselink, W. E. van Alpen, I. Joosten, J. C. P. Boog, M. C. Horzinek, and A. de Ronde. 1995. Vaccination against feline immunodeficiency virus using fixed infected cells. Vet. Immunol. Immunopathol. 46:139-149.
49. World Health Organization Working Group. 1994. Feasibility of developing live attenuated HIV vaccines: conclusions and recommendations. AIDS Res. Hum. Retroviruses 10:221-222.
50. Wrin, T., T. P. Loh, J. C. Vennari, H. Schuitemaker, and J. H. Nunberg. 1995. Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera. J. Virol. 69:39-48.
51. Yamamoto, J. K., C. D. Ackley, H. Zochlinski, H. Louie, E. Pembroke, M. Torten, H. Hansen, R. Munn, and T. Okuda. 1991. Development of IL-2-independent feline lymphoid cell lines chronically infected with feline immunodeficiency virus: importance for diagnostic reagents and vaccines. Intervirology 32:361-375
52. Yamamoto, J. K., T. Hohdatsu, R. A. Holmsted, R. Pu, H. Louie, H. A. Zochlinski, V. Acevedo, H. M. Johnson, G. A. Soulds, and M. B. Gardner. 1993. Experimental vaccine protection against homologous and hetetologous strains of feline immunodeficiency virus. J. Virol. 67:601-605.
53. Yamamoto, J. K., T. Okuda, C. D. Ackley, H. Louie, E. Pembroke, H. Zochlinski, R. J. Munn, and M. B. Gardner. 1991. Experimental vaccine protection against feline immunodeficiency virus. AIDS Res. Hum. Retroviruses 7:911-922.